• Pharma News - All the latest pharmaceutical news from across the web

« Page 1 of 2092 pages, displaying 1-10 of 20916 results »

Bayer partners with Seattle startups Litesprite and Prevencio on digital health efforts

Litesprite CEO Swatee Surve (right) with her mentor Jeanne Kehern, senior vice president of digital health and innovation at Bayer. (Bayer Photo)

Two Seattle-area startups were hand-picked by Bayer for a competitive program to create novel digital health solutions. It’s an endorsement of the region’s growing life science industry and of the potential for startups creating healthcare products with software and artificial intelligence.

Global Capsaicin Patches Market Data Analysis 2019-2025 – Endo International, GlaxoSmithKline, Mylan, ALLERGAN, Hisamitsu Pharmaceutical

Novartis takes step back from marketing Pear prescription digital therapeutics

Dive Brief: Novartis' Sandoz division is stepping back from a co-promotion agreement to market Pear Therapeutics' prescription digital therapeutics (PDTs) for treating substance and opioid abuse, known as reSET and reSET-O. Pear already has a standalone structure capable of handling sole marketing for the PDTs, the companies said in a Tuesday statement. Sandoz said the decision is tied to an organizational and leadership change, which "has resulted in a reinforced focus on and capital allocation for Sandoz core business." Dive Insight:

Pear and Sandoz launched reSET, the first PDT authorized by FDA, in November last year. They won FDA clearance for reSET-O, for opioid use disorder, the following month.

Sunitinib Drug Market 2019 Business Opportunities for Manufacturers: Pfizer – Pledge Times

Global Sunitinib Drug market Research Report includes data of the Top key industry players and their scope and share. The report offers types, investments, growth ratio, applications, manufacturers, opportunities, challenges. Future developments and latest contracts awarded in the market across different regions are demonstrated in the report.

Have Potential to become a good Portfolio:: Pfizer Inc., (NYSE: PFE)

On Wednesday the USA Stock Exchange company, Pfizer Inc., NYSE: PFE), the Trending-Graph. every buying and selling session display one-of-a-kind measures and patterns about, Drug Manufacturers – Major stock. Presently we observed the various factors that seen on close of last session. Toward the day’s end, it’s only a stock’s show that issues.

St Germain D J Co Has Cut By $626,890 Its Johnson & Johnson (JNJ) Position; J C Penney (JCP) Sentiment Is 0.94 | Mesa Weekly

Iowa to get nearly $2 million from Johnson & Johnson settlement | 1040 WHO

SC to receive more than $4M in Johnson & Johnson settlement

“Women in South Carolina and across the country were injured by the deceptive marketing of this product when they trusted that they were being helped,” Wilson said. “This settlement holds the companies accountable for violating state law and will prevent this deception from continuing.”

Wilson announces $116.9M settlement with Johnson & Johnson

COLUMBIA — Attorney General Alan Wilson today announced a multistate settlement along with 40 states and the District of Columbia requiring Johnson & Johnson and its subsidiary Ethicon, Inc. to pay nearly $116.9 million for their deceptive marketing of transvaginal surgical mesh devices.

Atty. General Josh Stein settles with Johnson & Johnson for $116.9 million

RALEIGH, N.C. (WNCT) Attorney General Josh Stein announced a $116.9 million multistate settlement with Johnson & Johnson and its subsidiary Ethicon Inc. over its deceptive marketing of transvaginal mesh devices.

« Page 1 of 2092 pages, displaying 1-10 of 20916 results »